Hydroxyrubicin
Hydroxyrubicin is an antitumor agent. Hydroxyrubicin can induce topoisomerase II-mediated DNA cleavage. Hydroxyrubicin induces DNA unwinding. Hydroxyrubicin has a significant inhibitory effect on tumor cells. Hydroxyrubicin can be used for the study of Multidrug-resistant (MDR) leukemia.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 73113-90-3
- 分子式: C27H28O12
- 分子量:544.50
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| K562 | IC50 |
0.856 μM
Compound: 11
|
Cytotoxicity against human K562 cells incubated for 2 hrs by cell titre blue viability assay
Cytotoxicity against human K562 cells incubated for 2 hrs by cell titre blue viability assay
|
[PMID: 37561481] |
| MEL-JUSO | IC50 |
1.904 μM
Compound: 11
|
Cytotoxicity against human MEL-JUSO cells incubated for 2 hrs by cell titre blue viability assay
Cytotoxicity against human MEL-JUSO cells incubated for 2 hrs by cell titre blue viability assay
|
[PMID: 37561481] |
| U2OS | IC50 |
6.793 μM
Compound: 11
|
Cytotoxicity against human U2OS cells incubated for 2 hrs by cell titre blue viability assay
Cytotoxicity against human U2OS cells incubated for 2 hrs by cell titre blue viability assay
|
[PMID: 37561481] |
体外実験
Hydroxyrubicin (1-10 μM, 30 min) induces topoisomerase II-mediated DNA cleavage in human c-myc-origin DNA[1].
Hydroxyrubicin (2.5-10 μM, 30 min) induces concentration-dependent DNA unwinding[1].
Hydroxyrubicin (1 h) appears to be slightly more cytotoxic than Doxorubicin (HY-15142A) in the sensitive KB3.1 cell line (IC50: 0.35 μM and 0.8 μM) and is 20-fold more cytotoxic on KB-V1 cells than doxorubicin (IC50: 2 μM and 40 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Healthy ICR Swiss mice[2].
-
Dosage:79.1 mg/kg
-
Administration:I.v., once
-
Result:Showed significant reduction in granulocytes.
-
Animal Model:Chronic cardiotoxicity was induced in healthy ICR Swiss mice through repeated administration[2].
-
Dosage:12 mg/kg
-
Administration:I.v., once weekly for 11 weeks
-
Result:Mild lesions were observed in 5 out of 10 mice.
The degree of myocardial fibrosis was relatively mild.
-
Animal Model:The model was established using male BDF1 mice (weighing 18-22 g) by intraperitoneal injection of 1×106 P388/Dox leukemia cells (drug-resistant strain)[2].
-
Dosage:25 mg/kg, 37.5 mg/kg, 50.0 mg/kg
-
Administration:I.v., once
-
Result:Showed activity in the range of 25-50 mg/kg and no toxicity or death.
化学情報
-
CAS 番号 73113-90-3
-
分子量 544.50
-
分子式 C27H28O12
-
SMILES
OC1=C2C([C@H](C[C@@](C(CO)=O)(O)C2)O[C@@]3([H])C[C@@H]([C@H](O)[C@H](C)O3)O)=C(O)C4=C1C(C5=CC=CC(OC)=C5C4=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)